Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Rectal Neoplasms 8Squamous Cell Carcinoma of Head and Neck 6Esophageal Neoplasms 6Oropharyngeal Neoplasms 5Uterine Cervical Neoplasms 4Head and Neck Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Hypopharyngeal Neoplasms 3Radiation Injuries 2Nasopharyngeal Carcinoma 2Lung Neoplasms 2Laryngeal Neoplasms 2Glioblastoma 2Esophageal Squamous Cell Carcinoma 2Vaginal Neoplasms 1Uterine Cervical Dysplasia 1Sinonasal Squamous Cell Carcinoma 1Rectal Malignant Neoplasms 1Postoperative Complications 1Pathologic Complete Response 1Papillomavirus Infections 1Pancreatic Neoplasms 1Ototoxicity 1Neoplasms 1Myelosuppression 1Mouth Neoplasms 1Margins of Excision 1Malignant Tumor of Lacrimal Drainage Structure 1Low Anterior Resection Syndrome 1Locally Advanced Hypopharyngeal Carcinoma 1

Interventions

sodium glycididazole 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Chemoradiotherapy × Chemoradiotherapy × Clear all
NCT06667622 2024-10-31

Sodium Glycididazole Reduces the Adverse Reactions of Concurrent Chemoradiotherapy

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Recruiting
40 enrolled

Chemoradiotherapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡